Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

被引:3
作者
Yu, Pak Lok Ivan [1 ,2 ]
Wang, Rachel R. [1 ,3 ]
Johnston, Grace [1 ,4 ]
Wang, Yaqiong [1 ,5 ]
Tammur, Pille [6 ]
Tamm, Anu [6 ]
Punab, Mari [7 ]
Rangel-Pozzo, Aline [1 ]
Mai, Sabine [1 ]
机构
[1] Univ Manitoba, Res Inst Oncol & Hematol, CancerCare Manitoba, Cell Biol, Winnipeg, MB R3C 2B7, Canada
[2] Univ British Columbia, Dept Bot & Zool, Vancouver, BC V5Z 4E8, Canada
[3] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2M6, Canada
[4] Univ Winnipeg, Dept Neurosci, Winnipeg, MB R3B 2E9, Canada
[5] Jilin Univ, Changchun 130021, Jilin, Peoples R China
[6] Tartu Univ Hosp, United Labs, EE-50406 Tartu, Estonia
[7] Tartu Univ Hosp, Dept Haematol & Bone Marrow Transplantat, Clin Haematol & Oncol, EE-50406 Tartu, Estonia
关键词
multiple myeloma; monoclonal gammopathy of undetermined significance; telomeres; centromeres; structural genome markers; genomic instability; 3-DIMENSIONAL ORGANIZATION; INTERPHASE NUCLEUS; IMAGE-ANALYSIS; LENGTH; CELLS; HETEROGENEITY; PROGRESSION; PROGNOSIS;
D O I
10.3390/cells8070723
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Both multiple myeloma (MM) and its precursor state of monoclonal gammopathy of undetermined significance (MGUS) are characterized by an infiltration of plasma cells into the bone marrow, but the mechanisms underlying the disease progression remain poorly understood. Previous research has indicated that 3D nuclear telomeric and centromeric organization may represent important structural indicators for numerous malignancies. Here we corroborate with previously noted differences in the 3D telomeric architecture and report that modifications in the nuclear distribution of centromeres may serve as a novel structural marker with potential to distinguish MM from MGUS. Our findings improve the current characterization of the two disease stages, providing two structural indicators that may become altered in the progression of MGUS to MM.
引用
收藏
页数:15
相关论文
共 46 条
[1]   Three-Dimensional Telomeric Analysis of Isolated Circulating Tumor Cells (CTCs) Defines CTC Subpopulations [J].
Awe, Julius Adebayo ;
Xu, Mark Chu ;
Wechsler, Janine ;
Benali-Furet, Naoual ;
Cayre, Yvon E. ;
Saranchuk, Jeff ;
Drachenberg, Darrel ;
Mai, Sabine .
TRANSLATIONAL ONCOLOGY, 2013, 6 (01) :51-U184
[2]   Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma [J].
Cagnetta, Antonia ;
Lovera, Davide ;
Grasso, Raffaella ;
Colombo, Nicoletta ;
Canepa, Letizia ;
Ballerini, Filippo ;
Calvio, Marino ;
Miglino, Maurizio ;
Gobbi, Marco ;
Lemoli, Roberto ;
Cea, Michele .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[3]   Genetics of multiple myeloma: another heterogeneity level? [J].
Corre, Jill ;
Munshi, Nikhil ;
Avet-Loiseau, Herve .
BLOOD, 2015, 125 (12) :1870-1876
[4]   Telomere shortening in patients with plasma cell disorders [J].
Cottliar, A ;
Pedrazzini, E ;
Corrado, C ;
Engelberger, MI ;
Narbaitz, M ;
Slavutsky, I .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (05) :334-340
[5]   Centromeres in cell division, evolution, nuclear organization and disease [J].
dos Santos Silva, Amanda Goncalves ;
Sarkar, Rahul ;
Harizanova, Jana ;
Guffei, Amanda ;
Mowat, Michael ;
Garini, Yuval ;
Mai, Sabine .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (06) :2040-2058
[6]   Ready or Not: Transitioning from Institutional Care to Community Care [J].
Fields, Noelle ;
Anderson, Keith ;
Dabelko-Schoeny, Holly .
JOURNAL OF HOUSING FOR THE ELDERLY, 2011, 25 (01) :3-17
[7]   Three-dimensional Nuclear Telomere Architecture Is Associated with Differential Time to Progression and Overall Survival in Glioblastoma Patients [J].
Gadji, Macoura ;
Fortin, David ;
Tsanaclis, Ana-Maria ;
Garini, Yuval ;
Katzir, Nir ;
Wienburg, Yifat ;
Yan, Ju ;
Klewes, Ludger ;
Klonisch, Thomas ;
Drouin, Regen ;
Mai, Sabine .
NEOPLASIA, 2010, 12 (02) :183-191
[8]   Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma [J].
Gonzalez, David ;
van der Burg, Mirjam ;
Garcia-Sanz, Ramon ;
Fenton, James A. ;
Langerak, Anton W. ;
Gonzalez, Marcos ;
van Dongen, Jacques J. M. ;
Miguel, Jesus F. San ;
Morgan, Gareth J. .
BLOOD, 2007, 110 (09) :3112-3121
[9]  
Hyatt S., 2011, BRIT J HAEMATOL, V178, P94
[10]   Multiple myeloma epidemiology and survival: A unique malignancy [J].
Kazandjian, Dickran .
SEMINARS IN ONCOLOGY, 2016, 43 (06) :676-681